Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 2, 2009, Pages

  Carreño, Flávia Regina ^a   Ji, Lisa L ^a   Cunningham, J Thomas ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Hypothalamus; Lipid rafts; Renin angiotensin; Supraoptic nucleus

Indexed keywords

RENIN; VANILLOID RECEPTOR 4; VASOPRESSIN; ARGIPRESSIN; TRPV4 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; HYPERVOLEMIA; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LIPID RAFT; LIVER CIRRHOSIS; MALE; NONHUMAN; PLASMA OSMOLALITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPRAOPTIC NUCLEUS; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; ANIMAL; BLOOD; BRAIN; CELL MEMBRANE; COMMON BILE DUCT; DISEASE MODEL; DRINKING; ELECTROLYTE BALANCE; EXPERIMENTAL LIVER CIRRHOSIS; HEMATOCRIT; LIGATION; METABOLISM; NERVE CELL; OSMOLARITY; PATHOPHYSIOLOGY; SCHWARTZ BARTTER SYNDROME; SECRETION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; ARGININE VASOPRESSIN; BLOTTING, WESTERN; BRAIN; BRAIN STEM; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; DRINKING; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; INAPPROPRIATE ADH SYNDROME; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MEMBRANE MICRODOMAINS; NEURONS; OSMOLAR CONCENTRATION; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SUPRAOPTIC NUCLEUS; TRPV CATION CHANNELS; WATER-ELECTROLYTE BALANCE;

EID: 61949445166     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90460.2008     Document Type: Article

References (97)

1. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102: 164-168, 1985.
2. Armstrong WE. Morphological and electrophysiological classification of hypothalamic supraoptic neurons. Prog Neurobiol 47: 291-339, 1995.
3. Bourque CW, Ciura S, Trudel E, Stachniak TJ, Sharif-Naeini R. Neurophysiological characterization of mammalian osmosensitive neurones. Exp Physiol 92: 499-505, 2007.
4. Bourque CW, Voisin DL, Chakfe Y. Stretch-inactivated cation channels: cellular targets for modulation of osmosensitivity in supraoptic neurons. Prog Brain Res 139: 85-94, 2002.
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
6. 2+ influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 278: 27208-27215, 2003.
7. Burg MB, Kwon ED, Kultz D. Osmotic regulation of gene expression. FASEB J 10: 1598-1606, 1996.
8. Cardenas A, Arroyo V. Hepatorenal syndrome. Ann Hepatol 2: 23-29, 2003.
9. Cardenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab 17: 607-622, 2003.
10. Cardenas A, Bataller R, Arroyo V. Mechanisms of ascites formation. Clin Liver Dis 4: 447-465, 2000.
11. Cardenas A, Gines P. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis. Semin Nephrol 21: 308-316, 2001.
12. Chakfe Y, Bourque CW. Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert. Nat Neurosci 3: 572-579, 2000.
13. Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 95: 8B-13B, 2005.
14. Chen L, Liu C, Liu L. Changes in osmolality modulate voltage-gated calcium channels in trigeminal ganglion neurons. Brain Res 1208C: 56-66, 2008.
15. Chini B, Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32: 325-338, 2004.
16. Ciura S, Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci 26: 9069-9075, 2006.
17. Cohen DM. The transient receptor potential vanilloid-responsive 1 and 4 cation channels: role in neuronal osmosensing and renal physiology. Curr Opin Nephrol Hypertens 16: 451-458, 2007.
18. De NE, Alepuz PM, Posas F. Dealing with osmostress through MAP kinase activation. EMBO Rep 3: 735-740, 2002.
19. Decaux G. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985. J Lab Clin Med 138: 18-21, 2001.
20. Essandri-Haber N, Dina OA, Joseph EK, Reichling DB, Levine JD. Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci 28: 1046-1057, 2008.
21. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352: 1884-1890, 2005.
22. Ferguson AV, Bains JS. Electrophysiology of the circumventricular organs. Front Neuroendocrinol 17: 440-475, 1996.
23. Fitts DA, Lane JR, Starbuck EM, Li CP. Drinking and blood pressure during sodium depletion or ANG II infusion in chronic cholestatic rats. Am J Physiol Regul Integr Comp Physiol 276: R23-R31, 1999.
24. Gines P, Abraham WT, Schrier RW. Vasopressin in pathophysiological states. Semin Nephrol 14: 384-397, 1994.
25. Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, Liard JF, Martin PY, Schrier RW. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 28: 851-864, 1998.
26. Girgrah N, Liu P, Collier J, Blendis L, Wong F. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis. Gut 46: 114-120, 2000.
27. Gitelman SE, Feldman BJ, Rosenthal SM. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients. Am J Med 119: S54-S58, 2006.
28. Gottlieb HB, Ji LL, Jones H, Penny ML, Fleming T, Cunningham JT. Differential effects of water and saline intake on water deprivationinduced c-Fos staining in the rat. Am J Physiol Regul Integr Comp Physiol 290: R1251-R1261, 2006.
29. Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70: 1067-1116, 1990.
30. Henriksen JH, Moller S. Hypertension and liver disease. Curr Hypertens Rep 6: 453-461, 2004.
31. Henriksen JH, Moller S. Liver cirrhosis and arterial hypertension. World J Gastroenterol 12: 678-685, 2006.
32. Henriksen JH, Moller S, Schifter S, Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J Hepatol 31: 712-718, 1999.
33. Ingert C, Grima M, Coquard C, Barthelmebs M, Imbs JL. Effects of dietary salt changes on renal renin-angiotensin system in rats. Am J Physiol Renal Physiol 283: F995-F1002, 2002.
34. Jeske NA, Glucksman MJ, Roberts JL. EP24.15 is associated with lipid rafts. J Neurosci Res 74: 468-473, 2003.
35. Jeske NA, Glucksman MJ, Roberts JL. Metalloendopeptidase EC3.4.24.15. is constitutively released from the exofacial leaflet of lipid rafts in GT1-7 cells. J Neurochem 90: 819-828, 2004.
36. Ji LL, Gottlieb HB, Penny ML, Fleming T, Toney GM, Cunningham JT. Differential effects of water deprivation and rehydration on Fos and FosB/DeltaFosB staining in the rat brain stem. Exp Neurol 203: 445-456, 2007.
37. Johnson AK. The sensory psychobiology of thirst and salt appetite. Med Sci Sports Exer 39: 1388-1400, 2007.
38. Kashani A, Landaverde C, Medici V, Rossaro L. Fluid retention in cirrhosis: pathophysiology and management. QJM 101: 71-85, 2008.
39. Kim JK, Michel JB, Soubrier F, Durr J, Corvol P, Schrier RW. Arginine vasopressin gene expression in chronic cardiac failure in rats. Kidney Int 38: 818-822, 1990.
40. Kirstetter P, Moreau R, Soupison T, Cailmail S, Hartleb M, Lebrec D. Role of sympathetic cardiovascular tone in control of arterial pressure in rats with cirrhosis. Liver 16: 263-266, 1996.
41. Kortas C, Bichet DG, Rouleau JL, Schrier RW. Vasopressin in congestive heart failure. J Cardiovasc Pharmacol 8 Suppl 7: S107-S110, 1986.
42. Kultz D, Burg M. Evolution of osmotic stress signaling via MAP kinase cascades. J Exp Biol 201: 3015-3021, 1998.
43. Kultz D, Burg MB. Intracellular signaling in response to osmotic stress. Contrib Nephrol 123: 94-109, 1998.
44. Lane JR, Purhar KK, Fitts DA. Drinking in sodium-depleted rats with bile duct, vena cava or portal vein obstruction. Physiol Behav 62: 1145-1154, 1997.
45. Lane JR, Starbuck EM, Johnson AK, Fitts DA. Effects of bile duct ligation and captopril on salt appetite and renin-aldosterone axis in rats. Physiol Behav 66: 419-425, 1999.
46. Lang DM, Lommel S, Jung M, Ankerhold R, Petrausch B, Laessing U, Wiechers MF, Plattner H, Stuermer CA. Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J Neurobiol 37: 502-523, 1998.
47. Liedtke W. TRPV4 as osmosensor: a transgenic approach. Pflügers Arch 451: 176-180, 2005.
48. Liedtke W. TRPV4 plays an evolutionary conserved role in the transduction of osmotic and mechanical stimuli in live animals. J Physiol 567: 53-58, 2005.
49. Liedtke W. TRPV channels' role in osmotransduction and mechanotransduction. Handb Exp Pharmacol 179: 473-487, 2007.
50. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103: 525-535, 2000.
51. Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4-/- mice. Proc Natl Acad Sci USA 100: 13698-13703, 2003.
52. Liedtke W, Tobin DM, Bargmann CI, Friedman JM. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci USA 100 Suppl 2: 14531-14536, 2003.
53. Liu M, Huang W, Wu D, Priestley JV. TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors. Eur J Neurosci 24: 1-6, 2006.
54. Lockwich TP, Liu X, Singh BB, Jadlowiec J, Weiland S, Ambudkar IS. Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains. J Biol Chem 275: 11934-11942, 2000.
55. Martin PY, Schrier RW. Pathogenesis of water and sodium retention in cirrhosis. Kidney Int Suppl 59: S43-S49, 1997.
56. McKinley MJ, Johnson AK. The physiological regulation of thirst and fluid intake. News Physiol Sci 19: 1-6, 2004.
57. McKinley MJ, Mathai ML, McAllen RM, McClear RC, Miselis RR, Pennington GL, Vivas L, Wade JD, Oldfield BJ. Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol 16: 340-347, 2004.
58. McKinley MJ, McAllen RM, Davern P, Giles ME, Penschow J, Sunn N, Uschakov A, Oldfield BJ. The sensory circumventricular organs of the mammalian brain. Adv Anat Embryol Cell Biol 172: III-122, back, 2003.
59. Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc 54: 345-353, 2006.
60. Mizuno A, Matsumoto N, Imai M, Suzuki M. Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol 285: C96-C101, 2003.
61. Natarajan SK, Basivireddy J, Ramachandran A, Thomas S, Ramamoorthy P, Pulimood AB, Jacob M, Balasubramanian KA. Renal damage in experimentally-induced cirrhosis in rats: Role of oxygen free radicals. Hepatology 43: 1248-1256, 2006.
62. Oldfield BJ, Davern PJ, Giles ME, Allen AM, Badoer E, McKinley MJ. Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol 13: 139-146, 2001.
63. Oren RM. Hyponatremia in congestive heart failure. Am J Cardiol 95: 2B-7B, 2005.
64. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
65. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-1676, 2002.
66. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54: 1790-1796, 2005.
67. Patel GP, Balk RA. Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clin Ther 29: 211-229, 2007.
68. Plant TD, Strotmann R. TRPV4. Handb Exp Pharmacol 189-205, 2007.
69. Rai A, Whaley-Connell A, McFarlane S, Sowers JR. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism. Am J Nephrol 26: 579-589, 2006.
70. Renaud LP, Bourque CW. Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Prog Neurobiol 36: 131-169, 1991.
71. Ros J, Fernandez-Varo G, Munoz-Luque J, Arroyo V, Rodes J, Gunnet JW, Demarest KT, Jimenez W. Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention. Br J Pharmacol 146: 654-661, 2005.
72. Saito S, Shingai R. Evolution of thermoTRP ion channel homologs in vertebrates. Physiol Genomics 27: 219-230, 2006.
73. 2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation 117: 1065-1074, 2008.
74. Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119: S47-S53, 2006.
75. Schrier RW, Fassett RG, Ohara M, Martin PY. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy. Proc Assoc Am Physicians 110: 407-411, 1998.
76. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355: 2099-2112, 2006.
77. Sharif Naeini R, Witty MF, Seguela P, Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci 9: 93-98, 2006.
78. Smith DM, McKenna K, Thompson CJ. Hyponatraemia. Clin Endocrinol (Oxf) 52: 667-678, 2000.
79. Song D, Sharkey KA, Breitman DR, Zhang Y, Lee SS. Disordered central cardiovascular regulation in portal hypertensive and cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 280: G420-G430, 2001.
80. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996.
81. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2: 695-702, 2000.
82. Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO, Plattner H. Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol Biol Cell 12: 3031-3045, 2001.
83. Sunn N, McKinley MJ, Oldfield BJ. Circulating angiotensin II activates neurones in circumventricular organs of the lamina terminalis that project to the bed nucleus of the stria terminalis. J Neuroendocrinol 15: 725-731, 2003.
84. Taylor AC, McCarthy JJ, Stocker SD. Mice lacking the transient receptor vanilloid potential 1 channel display normal thirst responses and central Fos activation to hypernatremia. Am J Physiol Regul Integr Comp Physiol 294: R1285-R1293, 2008.
85. Therapondos G, Hol L, Benjaminov F, Wong F. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis. Hepatology 44: 640-649, 2006.
86. Thuluvath PJ, Maheshwari A, Wong F, Yoo HW, Schrier RW, Parikh C, Steare S, Korula J. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study. Aliment Pharmacol Ther 24: 973-982, 2006.
87. Van LF, Leo O. Membrane lipid rafts: new targets for immunoregulation. Curr Mol Med 2: 557-570, 2002.
88. Vennekens R, Owsianik G, Nilius B. Vanilloid transient receptor potential cation channels: an overview. Curr Pharm Des 14: 18-31, 2008.
89. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 17: 471-503, 2003.
90. Voets T, Prenen J, Vriens J, Watanabe H, Janssens A, Wissenbach U, Bodding M, Droogmans G, Nilius B. Molecular determinants of permeation through the cation channel TRPV4. J Biol Chem 277: 33704-33710, 2002.
91. Watson AM, Hood SG, May CN. Mechanisms of sympathetic activation in heart failure. Clin Exp Pharmacol Physiol 33: 1269-1274, 2006.
92. Wilson HJ, Shutt LE. Syndrome of inappropriate ADH secretion in a woman with preeclampsia. Int J Obstet Anesth 16: 360-362, 2007.
93. Wong F, Liu P, Blendis L. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis. Gut 49: 847-851, 2001.
94. Xi D, Kusano K, Gainer H. Quantitative analysis of oxytocin and vasopressin messenger ribonucleic acids in single magnocellular neurons isolated from supraoptic nucleus of rat hypothalamus. Endocrinology 140: 4677-4682, 1999.
95. Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, Cohen DM. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem 278: 11520-11527, 2003.
96. Yang YY, Lin HC, Huang YT, Lee TY, Hou MC, Lee FY, Liu RS, Chang FY, Lee SD. Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension. J Hepatol 36: 600-606, 2002.
97. Zajchowski LD, Robbins SM. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem 269: 737-752, 2002.